The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Gallagher Cam since 2020.
This trader's CIK number is 1557832.
At the time of last reporting, Gallagher Cam was the President, Interim CFO of Zentalis Pharmaceuticals, Inc.. (stock ticker symbol ZNTL).
Also see all insider trading activities at Zentalis Pharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2020 | OCUP | 8,865 | $0 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2024 | ZNTL | 0 | $0 | 10,770 | $128,391 | 0 | $0 |
| 2023 | ZNTL | 0 | $0 | 79,601 | $1,863,988 | 0 | $0 |
| 2022 | ZNTL | 0 | $0 | 172,062 | $6,439,232 | 0 | $0 |
| 2021 | ZNTL | 0 | $0 | 176,739 | $9,973,059 | 0 | $0 |
| 2020 | ZNTL | 0 | $0 | 75,212 | $2,985,167 | 0 | $0 |
1. Ocuphire Pharma, Inc. (OCUP)
2. Zentalis Pharmaceuticals, Inc. (ZNTL)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2020-11-19 | OCUP | Buy | 8,865 | .00 | 0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2024-05-31 | ZNTL | Sale | 9,597 | 11.98 | 114,972 |
| 2024-02-12 | ZNTL | Sale | 1,173 | 11.44 | 13,419 |
| 2023-05-31 | ZNTL | Sale | 27,768 | 26.30 | 730,381 |
| 2023-02-13 | ZNTL | Sale | 3,332 | 20.42 | 68,052 |
| 2023-02-14 | ZNTL | Sale | 8,501 | 19.96 | 169,705 |
| 2023-02-06 | ZNTL | Sale | 10,000 | 22.63 | 226,280 |
| 2023-01-17 | ZNTL | Sale | 10,000 | 24.49 | 244,910 |
| 2023-01-05 | ZNTL | Sale | 10,000 | 21.23 | 212,330 |
| 2023-01-05 | ZNTL | Sale | 10,000 | 21.23 | 212,330 |
| 2022-11-15 | ZNTL | Sale | 12,500 | 23.10 | 288,750 |
| 2022-11-07 | ZNTL | Sale | 12,500 | 23.95 | 299,375 |
| 2022-11-08 | ZNTL | Sale | 12,374 | 23.56 | 291,543 |
| 2022-10-17 | ZNTL | Sale | 12,500 | 23.51 | 293,875 |
| 2022-10-06 | ZNTL | Sale | 10,000 | 22.62 | 226,180 |
| 2022-10-05 | ZNTL | Sale | 12,500 | 22.38 | 279,687 |
| 2022-09-15 | ZNTL | Sale | 12,500 | 25.34 | 316,812 |
| 2022-09-16 | ZNTL | Sale | 10,000 | 24.68 | 246,850 |
| 2022-04-05 | ZNTL | Sale | 10,000 | 51.17 | 511,700 |
| 2022-03-15 | ZNTL | Sale | 10,000 | 42.31 | 423,130 |
| 2022-03-07 | ZNTL | Sale | 10,000 | 45.23 | 452,329 |
| 2022-02-15 | ZNTL | Sale | 10,000 | 52.04 | 520,379 |
| 2022-02-14 | ZNTL | Sale | 7,188 | 50.36 | 362,002 |
| 2022-02-07 | ZNTL | Sale | 10,000 | 53.55 | 535,450 |
| 2022-01-18 | ZNTL | Sale | 10,000 | 63.05 | 630,460 |
| 2022-01-05 | ZNTL | Sale | 10,000 | 76.07 | 760,710 |
| 2021-12-15 | ZNTL | Sale | 10,000 | 75.20 | 752,030 |
| 2021-12-06 | ZNTL | Sale | 10,000 | 71.33 | 713,300 |
| 2021-11-15 | ZNTL | Sale | 10,000 | 75.82 | 758,180 |
| 2021-11-05 | ZNTL | Sale | 10,000 | 82.95 | 829,520 |
| 2021-10-01 | ZNTL | Sale | 10,000 | 66.16 | 661,550 |
| 2021-09-01 | ZNTL | Sale | 10,000 | 67.62 | 676,200 |
| 2021-08-02 | ZNTL | Sale | 10,000 | 51.84 | 518,380 |
| 2021-07-06 | ZNTL | Sale | 15,798 | 47.65 | 752,711 |
| 2021-07-07 | ZNTL | Sale | 2,572 | 47.04 | 120,986 |
| 2021-07-02 | ZNTL | Sale | 10,000 | 49.95 | 499,460 |
| 2021-06-01 | ZNTL | Sale | 10,000 | 54.29 | 542,910 |
| 2021-05-03 | ZNTL | Sale | 10,000 | 58.66 | 586,650 |
| 2021-04-05 | ZNTL | Sale | 28,204 | 44.01 | 1,241,314 |
| 2021-04-06 | ZNTL | Sale | 165 | 43.26 | 7,138 |
| 2021-03-01 | ZNTL | Sale | 10,000 | 41.69 | 416,860 |
| 2021-02-01 | ZNTL | Sale | 10,000 | 37.71 | 377,090 |
| 2021-01-04 | ZNTL | Sale | 10,000 | 51.88 | 518,780 |
| 2020-12-24 | ZNTL | Sale | 18,473 | .00 | 0 |
| 2020-12-04 | ZNTL | Sale | 7,474 | 50.97 | 380,934 |
| 2020-12-08 | ZNTL | Sale | 22,573 | 56.22 | 1,269,144 |
| 2020-12-07 | ZNTL | Sale | 6,692 | 52.87 | 353,779 |
| 2020-12-02 | ZNTL | Sale | 10,000 | 51.26 | 512,610 |
| 2020-11-23 | ZNTL | Sale | 10,000 | 46.87 | 468,700 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Gallagher Cam (President, Interim CFO of Zentalis Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.